Suicide Gene Therapy
Leishmania Amastigotes Susceptible to HSV-TK/GCV Killing
Published in Gene Therapy Weekly, March 24th, 1997
HSV-TK/GCV suicide gene therapy has been a useful tool and/or therapy in several areas of medical science. It has been used as a negative dominant selectable marker; used to study lineage formation in cultured cells and transgenic animals; used to achieve conditional ablation of targeted cell types; as a gene therapy to selectively treat tumor cells; and has also been studied as a method of controlling HIV infection.
Anthony Muyombwe and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1997-03-24)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Modified Herpes Simplex Virus Shows Promise as an Anticancer Agent - Conference Coverage (Retrovirus)
HIV DNA Vaccine Mix Offers Live Vaccine Substitute - Endometrial Gene Therapy
Gene Transfer to the Uterine Endometrium: In Vitro and In Vivo Results - Genetics
DNA Sequencing Mutation Studies Announced - Genetics (Cystic Fibrosis)
Researcher Being Investigated for Illegal Experimental Research - Genetics (Obesity)
Notice of Allowance Received for UCPH Gene in Obesity - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
